» Articles » PMID: 30792653

Anti-thrombosis Effects and Mechanisms by Xueshuantong Capsule Under Different Flow Conditions

Overview
Journal Front Pharmacol
Date 2019 Feb 23
PMID 30792653
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Xueshuantong capsule (XST) is a patented traditional Chinese medicine used for the prevention and treatment of thrombosis. The molecular mechanism of anti-thrombotic effect of XST was investigated through the cross-talk among the platelets/leukocytes, endothelial cells (ECs), and flow shear stress. The Bioflux 1000 system was used to generate two levels of shear stress conditions: 0.1 and 0.9 Pa. Bioflux Metamorph microscopic imaging system was used to analyze the adhesion cell numbers. Protein expressions were detected by western blotting and flow cytometry. The flow-cytometry results showed that under 0.1 Pa flow, XST decreased ADP induced platelets CD62p surface expression in a concentration-dependent manner. Under 0.9 Pa flow, XST at a concentration of 0.15 g⋅L reduced the platelets activation by 29.5%, and aspirin (ASA) showed no inhibitory effects. XST showed similar efficiency on monocytes adhesion both under 0.1 and 0.9 Pa flow conditions, and the inhibition rate was 30.2 and 28.3%, respectively. Under 0.9 Pa flow, the anti-adhesive effects of XST might be associated with the suppression of VE-cadherin and Cx43 in HUVECs. Blood flow not only acts as a drug transporter, but also exerts its effects to influence the pharmacodynamics of XST. Effects of XST on inhibiting platelets activation and suppressing platelets/leukocytes adhesion to injured ECs are not only concentration-dependent, but also shear stress-dependent. The mechanic forces combined with traditional Chinese medicine may be used as a precise treatment for cardiovascular diseases.

Citing Articles

Network pharmacology analysis and clinical verification of saponins in deep venous thrombosis prevention.

Yan B, Ning Y, Guo J, Liu L, Wang C Biomed Rep. 2024; 22(1):8.

PMID: 39559819 PMC: 11572032. DOI: 10.3892/br.2024.1886.


Proteomic analysis revealed the pharmacological mechanism of Xueshuantong injection in preventing early acute myocardial infarction injury.

Wang A, Li Y, Wang Z, Xin G, You Y, Sun M Front Pharmacol. 2023; 13:1010079.

PMID: 36618918 PMC: 9811672. DOI: 10.3389/fphar.2022.1010079.


Mechanism and Potential Target of Blood-Activating Chinese Botanical Drugs Combined With Anti-Platelet Drugs: Prevention and Treatment of Atherosclerotic Cardiovascular Diseases.

Li D, Li Y, Yang S, Yu Z, Xing Y, Wu M Front Pharmacol. 2022; 13:811422.

PMID: 35721128 PMC: 9204194. DOI: 10.3389/fphar.2022.811422.


Inhibition of Shear-Induced Platelet Aggregation by Xueshuantong via Targeting Piezo1 Channel-Mediated Ca Signaling Pathway.

Liu L, Zhang Q, Xiao S, Sun Z, Ding S, Chen Y Front Pharmacol. 2021; 12:606245.

PMID: 33841141 PMC: 8025832. DOI: 10.3389/fphar.2021.606245.


Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy.

Yao H, Xin D, Zhan Z, Li Z Evid Based Complement Alternat Med. 2021; 2021:6642600.

PMID: 33747106 PMC: 7954618. DOI: 10.1155/2021/6642600.


References
1.
Kyrle P, Eichinger S . Deep vein thrombosis. Lancet. 2005; 365(9465):1163-74. DOI: 10.1016/S0140-6736(05)71880-8. View

2.
Wan J, Yang F, Li S, Wang Y, Cui X . Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. J Pharm Biomed Anal. 2006; 41(5):1596-601. DOI: 10.1016/j.jpba.2006.01.058. View

3.
Liao F, Li M, Han D, Cao J, Chen K . Biomechanopharmacology: a new borderline discipline. Trends Pharmacol Sci. 2006; 27(6):287-9. DOI: 10.1016/j.tips.2006.04.001. View

4.
Bergan J, Schmid-Schonbein G, Smith P, Nicolaides A, Boisseau M, Eklof B . Chronic venous disease. N Engl J Med. 2006; 355(5):488-98. DOI: 10.1056/NEJMra055289. View

5.
Chatzizisis Y, Coskun A, Jonas M, Edelman E, Feldman C, Stone P . Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007; 49(25):2379-93. DOI: 10.1016/j.jacc.2007.02.059. View